Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 5Withdrawn 4Unknown 3Recruiting 3Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Vulvar Neoplasms 1Skin Neoplasms 1Melanoma 1Gynecological Cancers 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × Electrochemotherapy × Clear all
NCT07443475 2026-03-02

Electrochemotherapy for Recurrent Vulvar Cancer

Institute of Oncology Ljubljana

Phase 2 Recruiting
13 enrolled
Gynecologic

Vulvar Neoplasms

NCT07404605 2026-02-19

Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma

Institute of Oncology Ljubljana

Phase NA Recruiting
150 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting
30 enrolled

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡